Eevia revises financial targets
The new Board of Eevia Health Plc ("Eevia" or "The Company") has approved a new strategic business plan for 2025 - 2026. The new strategy is also a turnaround plan for the Company, and in connection with this plan, the Company has revised its financial targets for 2025 and 2026.
The management team at Eevia conducted a thorough performance analysis from September to October to find a new path and turn the company's development towards growth and profitability. The new Board has approved the turnaround plan as the Company's new strategic business plan for 2025 - 2026. A summary of the Business Plan will be published soon.
In connection with this plan, the company is revising its financial targets for 2025 and 2026. The revenue target 2025 is MEUR 3, with an EBITDA of KEUR 100. For 2026, the revenue target is MEUR 5, with MEUR 1 as the EBITDA target.
The targets are set conservatively on purpose to ensure their credibility. However, the Company considers that the potential performance has a significant upside.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected] or [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as Bilberry, lingonberry, Chaga mushroom, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
